Last $1.82 USD
Change Today +0.02 / 1.11%
Volume 233.6K
DSCO On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

W. Thomas Amick

Chief Executive Officer, President and Director, Dendreon Corp.
AgeTotal Calculated CompensationThis person is connected to 35 board members in 7 different organizations across 9 different industries.

See Board Relationships
71--

Background*

Mr. W. Thomas Amick, also known as Tom, has been Chief Executive Officer and President of Dendreon Corp. since July 30, 2014. Mr. Amick served as the Chief Executive Officer of Discovery Laboratories Inc. from October 18, 2010 to January 4, 2013 and previously served as its Interim Chief Executive Officer from August 13, 2009 to October 18, 2010. Mr. Amick served as the Executive Chairman of Aldagen, Inc from March 2005 to February 23, 2010, Chief Executive Officer from ...

Read Full Background

Corporate Headquarters*

2600 Kelly Road
Warrington, Pennsylvania 18976

United States

Phone: 215-488-9300
Fax: --

Board Members Memberships*

Chairman
2004-N/A
Director and Member of Compensation Committee
2004-N/A
Former Chairman and Chief Executive Officer
2004-Present
Director
2005-N/A
Former Chief Executive Officer, President and Director
2005-Present
Director
2014-Present
Chief Executive Officer, President and Director

Education*

BA
Elon University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DSCO:US $1.82 USD +0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James A. Bianco M.D.Principal Founder, Chief Executive Officer, President, Executive Director, Member of Scientific Advisory Board and Member of Executive Committee
CTI BioPharma Corp.
$1.3M
James M. Gower Chairman, Chief Executive Officer and Member of Finance Committee
Rigel Pharmaceuticals, Inc.
$695.1K
Rajesh C. Shrotriya M.D.Chairman, Chief Executive Officer, Chairman of Product Acquisition Committee and Chairman of Placement Committee
Spectrum Pharmaceuticals, Inc.
$1.8M
Aijaz Tobaccowalla Managing Director, Additional Non-Executive Director, Member of Share Transfer Committee, Member of Audit Committee and Member of Shareholders' / Investors' Grievance Committee
Wyeth Limited
--
Aijaz Tobaccowalla Managing Director, Additional Director and Member of Board Administrative Committee
Pfizer Limited
17.6M
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DISCOVERY LABORATORIES INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.